Literature DB >> 30471215

A study of biological and lifestyle factors, including within-subject variation, affecting concentrations of growth differentiation factor 15 in serum.

Magdalena Krintus1, Federica Braga2,3, Marek Kozinski4, Simona Borille3, Jacek Kubica5, Grazyna Sypniewska6, Mauro Panteghini2,3.   

Abstract

Background Growth differentiation factor 15 (GDF-15) is an emerging cardiovascular biomarker, and a fully automated immunoassay has recently become available. The objectives of the study were to identify biological and lifestyle factors affecting serum GDF-15 concentrations and derive robust reference intervals, and to estimate GDF-15 within-subject biological variation and derived indices. Methods A presumably healthy population of 533 questionnaire-screened adults was used to identify the biological and lifestyle determinants of serum GDF-15. Following stringent exclusion criteria, a final group of 173 individuals was selected to establish GDF-15 reference interval. Twenty-six healthy volunteers were enrolled in the biological variation substudy. Results Using a multiple regression model, age, B-type natriuretic peptide and C-reactive protein as well as smoking status were significantly related to serum GDF-15 concentrations. The upper reference limit (URL) for serum GDF-15 concentrations (90% confidence interval [CI]) was 866 ng/L (733-999 ng/L), with no sex-related difference. Although GDF-15 tended to increase with age, the weak dependence of marker from age does not justify age-related URL. The within-subject CV was 6.3% (95% CI, 4.5%-8.5%), with no sex difference in intraindividual variances. The reference change value (RCV) for GDF-15 was 23%, and two are the specimens required to ensure that the mean GDF-15 result is within ±10% of the individual's homeostatic set point. Conclusions By identifying the main factors influencing serum GDF-15 concentrations, we robustly established the URL to be applied in adult population. As intraindividual variation of GDF-15 is relatively low, monitoring longitudinal changes in its concentrations over time using RCV can be a good alternative for interpreting GDF-15 in clinical setting.

Entities:  

Keywords:  biological variation; growth differentiation factor 15; reference limits

Mesh:

Substances:

Year:  2019        PMID: 30471215     DOI: 10.1515/cclm-2018-0908

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Longitudinal course of GDF15 levels before acute hospitalization and death in the general population.

Authors:  Juliette Tavenier; Ove Andersen; Jan O Nehlin; Janne Petersen
Journal:  Geroscience       Date:  2021-03-24       Impact factor: 7.713

2.  Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort.

Authors:  Paul Welsh; Dorien M Kimenai; Riccardo E Marioni; Caroline Hayward; Archie Campbell; David Porteous; Nicholas L Mills; Stephen O'Rahilly; Naveed Sattar
Journal:  Clin Chem Lab Med       Date:  2022-08-18       Impact factor: 8.490

3.  Biological variation, reference change values and index of individuality of GDF-15.

Authors:  Cindhya Sithiravel; Ragnhild Røysland; Bashir Alaour; Marit Sverresdotter Sylte; Janniche Torsvik; Heidi Strand; Michael Marber; Torbjørn Omland; Kristin Moberg Aakre
Journal:  Clin Chem Lab Med       Date:  2021-10-14       Impact factor: 8.490

4.  Prognostic Value of GDF-15 in Predicting Prolonged Intensive Care Stay following Cardiac Surgery: A Pilot Study.

Authors:  Henry Barton; Elisabeth Zechendorf; Dirk Ostareck; Antje Ostareck-Lederer; Christian Stoppe; Rashad Zayat; Tim Simon-Philipp; Gernot Marx; Johannes Bickenbach
Journal:  Dis Markers       Date:  2021-06-15       Impact factor: 3.434

5.  Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients.

Authors:  Toshiaki Nakajima; Ikuko Shibasaki; Tatsuya Sawaguchi; Akiko Haruyama; Hiroyuki Kaneda; Takafumi Nakajima; Takaaki Hasegawa; Takuo Arikawa; Syotaro Obi; Masashi Sakuma; Hironaga Ogawa; Shigeru Toyoda; Fumitaka Nakamura; Shichiro Abe; Hirotsugu Fukuda; Teruo Inoue
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.